Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
17.69
+2.83 (19.04%)
At close: Mar 9, 2026, 4:00 PM EDT
17.70
+0.01 (0.06%)
After-hours: Mar 9, 2026, 4:11 PM EDT
Dyne Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 2,919 | 3,221 | 2,398 | 816 | 604 | 606 | |
| Market Cap Growth | 105.05% | 34.33% | 193.72% | 35.12% | -0.32% | -36.50% | |
| Enterprise Value | 1,874 | 2,549 | 1,699 | 687 | 387 | 233 | |
| Last Close Price | 14.86 | 19.56 | 23.56 | 13.30 | 11.59 | 11.89 | |
| PB Ratio | 2.52 | 3.31 | 3.81 | 8.94 | 2.39 | 1.65 | |
| P/TBV Ratio | 2.90 | 3.31 | 3.81 | 8.94 | 2.39 | 1.65 | |
| Debt / Equity Ratio | 0.17 | 0.17 | 0.04 | 0.30 | 0.12 | 0.09 | |
| Net Debt / Equity Ratio | -0.97 | -0.97 | -0.98 | -1.05 | -0.89 | -0.93 | |
| Net Debt / EBITDA Ratio | 2.02 | 2.02 | 1.81 | 0.40 | 1.33 | 2.31 | |
| Net Debt / FCF Ratio | 2.22 | 2.22 | 2.10 | 0.51 | 1.44 | 2.79 | |
| Quick Ratio | 21.94 | 21.94 | 15.20 | 2.41 | 9.12 | 13.11 | |
| Current Ratio | 22.25 | 22.25 | 15.60 | 2.53 | 9.46 | 13.31 | |
| Return on Equity (ROE) | -55.71% | -55.71% | -88.03% | -137.31% | -54.18% | -42.02% | |
| Return on Assets (ROA) | -31.16% | -31.16% | -50.20% | -64.21% | -29.20% | -24.07% | |
| Return on Capital Employed (ROCE) | -41.20% | -41.20% | -53.00% | -212.40% | -61.40% | -37.80% | |
| Earnings Yield | -15.85% | -13.86% | -13.24% | -28.90% | -27.82% | -24.63% | |
| FCF Yield | -15.06% | -13.16% | -12.29% | -23.14% | -25.94% | -20.33% | |
| Buyback Yield / Dilution | -36.43% | -36.43% | -57.74% | -14.83% | -2.13% | -253.54% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.